Top Markets
#1 MowCat MowCat +26.72%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.90%
#3 Versatize Coin Versatize Coin +16.67%
#4 OriginTrail OriginTrail +12.28%
#5 Pons Pons +11.65%
#6 Wrapped NXM Wrapped NXM +10.43%
#7 QuantixAI QuantixAI +9.67%
#8 Collector Crypt Collector Crypt +9.04%
#9 StonkBroker StonkBroker +8.80%
#10 Siren Siren +8.12%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
株式のランク #20753
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
株価
$2.33
時価総額
$122.59M
変化（1日）
0.41%
変化（1年）
110.45%
国
TW
取引 Great Novel Therapeutics Biotech & Medicals (7427)

カテゴリー

Healthcare
Great Novel Therapeutics Biotech & Medicals（7427）のP/B比率
2026 時点のP/B比率 TTM: 0
Great Novel Therapeutics Biotech & Medicals の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Great Novel Therapeutics Biotech & Medicals の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH